Literature DB >> 27422629

Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein.

Esaú E Rodríguez1, Trinidad Arcos-López1, Lidia G Trujano-Ortiz1, Claudio O Fernández2, Felipe J González1, Alberto Vela1, Liliana Quintanar3.   

Abstract

Amyloid aggregation of α-synuclein (AS) is one of the hallmarks of Parkinson's disease. The interaction of copper ions with the N-terminal region of AS promotes its amyloid aggregation and metal-catalyzed oxidation has been proposed as a plausible mechanism. The AS(1-6) fragment represents the minimal sequence that models copper coordination to this intrinsically disordered protein. In this study, we evaluated the role of methionine residues Met1 and Met5 in Cu(II) coordination to the AS(1-6) fragment, and in the redox activity of the Cu-AS(1-6) complex. Spectroscopic and electronic structure calculations show that Met1 may play a role as an axial ligand in the Cu(II)-AS(1-6) complex, while Met5 does not participate in metal coordination. Cyclic voltammetry and reactivity studies demonstrate that Met residues play an important role in the reduction and reoxidation processes of this complex. However, Met1 plays a more important role than Met5, as substitution of Met1 by Ile decreases the reduction potential of the Cu-AS(1-6) complex by ~80 mV, causing a significant decrease in its rate of reduction. Reoxidation of the complex by oxygen results in oxidation of the Met residues to sulfoxide, being Met1 more susceptible to copper-catalyzed oxidation than Met5. The sulfoxide species can suffer elimination of methanesulfenic acid, rendering a peptide with no thioether moiety, which would impair the ability of AS to bind Cu(I) ions. Overall, our study underscores the important roles that Met1 plays in copper coordination and the reactivity of the Cu-AS complex.

Entities:  

Keywords:  Alpha-synuclein; Circular dichroism; Copper; DFT; EPR; Electronic structure

Mesh:

Substances:

Year:  2016        PMID: 27422629     DOI: 10.1007/s00775-016-1376-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  58 in total

1.  Generalized Gradient Approximation Made Simple.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-10-28       Impact factor: 9.161

2.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.

Authors:  Nelson B Cole; Diane D Murphy; Jacob Lebowitz; Luca Di Noto; Rodney L Levine; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

3.  The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse α-synuclein.

Authors:  Lijuan Kang; Kuen-Phon Wu; Michele Vendruscolo; Jean Baum
Journal:  J Am Chem Soc       Date:  2011-08-08       Impact factor: 15.419

4.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

Review 5.  Methionine oxidation, alpha-synuclein and Parkinson's disease.

Authors:  Charles B Glaser; Ghiam Yamin; Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-11-25

6.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

7.  The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.

Authors:  Dhiman Ghosh; Mrityunjoy Mondal; Ganesh M Mohite; Pradeep K Singh; Priyatosh Ranjan; A Anoop; Saikat Ghosh; Narendra Nath Jha; Ashutosh Kumar; Samir K Maji
Journal:  Biochemistry       Date:  2013-09-23       Impact factor: 3.162

Review 8.  Oxidative modifications of alpha-synuclein.

Authors:  Harry Ischiropoulos
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

9.  A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins.

Authors:  Robert Bussell; David Eliezer
Journal:  J Mol Biol       Date:  2003-06-13       Impact factor: 5.469

10.  Site-specific interaction between α-synuclein and membranes probed by NMR-observed methionine oxidation rates.

Authors:  Alexander S Maltsev; Jue Chen; Rodney L Levine; Ad Bax
Journal:  J Am Chem Soc       Date:  2013-02-14       Impact factor: 15.419

View more
  6 in total

1.  Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.

Authors:  Jenifer S Calvo; Neha V Mulpuri; Alex Dao; Nabeeha K Qazi; Gabriele Meloni
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

2.  Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.

Authors:  Raniki Kumari; Roshan Kumar; Sanjay Kumar; Abhishek Kumar Singh; Pranita Hanpude; Deepak Jangir; Tushar Kanti Maiti
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

3.  Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.

Authors:  Elena Atrián-Blasco; Paulina Gonzalez; Alice Santoro; Bruno Alies; Peter Faller; Christelle Hureau
Journal:  Coord Chem Rev       Date:  2018-09-15       Impact factor: 22.315

Review 4.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 5.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

6.  Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease.

Authors:  Clémence Cheignon; Megan Jones; Elena Atrián-Blasco; Isabelle Kieffer; Peter Faller; Fabrice Collin; Christelle Hureau
Journal:  Chem Sci       Date:  2017-05-04       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.